Welcome to our dedicated page for ETRACS Whitney US Critical Technologies ETN SEC filings (Ticker: WUCT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
UBS AG filings for WUCT document foreign private issuer reporting and securities-offering disclosures for the ETRACS Whitney US Critical Technologies ETN. The record includes Form 6-K reports, Form 20-F references, IFRS consolidated financial information, capitalization disclosures, and debt and equity presentation for UBS AG and its subsidiaries.
Registration-related filings also incorporate Form F-3 materials and legal opinion exhibits for UBS AG securities offerings. These disclosures address the issuer's reporting framework, capital structure, funding from UBS Group AG, and the formal documentation supporting registered securities.
UBS AG filed a 424B2 prospectus supplement for the issuance of Trigger Autocallable Contingent Yield Notes linked to the common stock of Meta Platforms (META).
The Notes offer a contingent coupon of 9.97%–10.97% per annum, payable quarterly only when the closing price of META on the relevant observation date is at or above a 75% coupon barrier. An automatic call is triggered if META closes at or above the initial level on any observation date before maturity, returning principal plus the contingent coupon.
If not called, repayment of principal at maturity (30 June 2026) is contingent. Investors receive full principal back only if META’s final level is at or above a 75% downside threshold; otherwise, they incur the same percentage loss as META, potentially losing their entire investment. The Notes are unsecured, unsubordinated debt of UBS AG, exposing holders to UBS credit risk. They will not be listed on any exchange, and secondary market liquidity is uncertain.
The issue price is $10 per Note with a minimum purchase of 100 Notes. Estimated initial value is $9.54–$9.79, reflecting underwriting discount ($0.15 per Note) and UBS internal models. Settlement is expected T+2 (30 June 2025); secondary trades before T+1 require alternative settlement. Key risks highlighted include principal-at-risk structure, potential non-payment of coupons, credit exposure to UBS, and limited liquidity.
UBS AG (Ticker: WUCT) filed Amendment No. 1 to its June 20, 2025 pricing supplement under Rule 424(b)(3) for a $1.237 million issuance of Trigger Callable Contingent Yield Notes due June 25, 2029.
The Notes pay a contingent coupon of 8.50% p.a. only when the closing levels of the Dow Jones Industrial Average, Russell 2000 and S&P 500 are each at or above their 70 % coupon barriers on the corresponding monthly observation date. UBS may, at its sole discretion, call the Notes in whole on any observation date beginning after six months; if called, investors receive par plus the current coupon.
At maturity, investors receive par only if every index finishes at or above its 60 % downside threshold; otherwise the redemption value is reduced one-for-one with the worst-performing index, exposing investors to full downside market risk and potential total loss of principal. The offering price is $1,000 per Note, less a $7.50 underwriting discount; estimated initial value is $961.70, reflecting UBS’ internal funding rate. The Notes are unsecured, unsubordinated obligations of UBS, not FDIC-insured, and will not be listed on any exchange, limiting secondary-market liquidity.
Key dates include Trade Date 6/20/25, Settlement Date 6/25/25, monthly observation dates, Final Valuation Date 6/20/29 and Maturity 6/25/29. The filing reiterates extensive risk factors, emphasizing credit risk, market risk of each underlying index, call risk, valuation uncertainty and liquidity constraints.
UBS AG London Branch is offering Contingent Income Auto-Callable Securities linked to the common stock of Citigroup Inc. (ticker “C UN”). The notes have a $1,000 denomination, are expected to price on 3 July 2025 and mature on 7 July 2028, unless called earlier.
The product pays a quarterly contingent coupon of $26.625 (10.65% p.a.) only if Citigroup’s closing share price on a determination date is at or above the 70% downside threshold. Should the price meet or exceed the 100% call threshold on any quarterly date, UBS will redeem the notes early at par plus the coupon. Investors receive no participation in upside; principal is protected only if the final price is at or above the threshold. If the final price falls below 70% of the initial level, repayment equals the share performance (cash-settled), exposing holders to losses up to 100% of principal.
The securities are unsecured, unsubordinated obligations of UBS; all payments are subject to the issuer’s credit risk. Estimated initial value is $940–$970, implying a 3–6% issuance premium over fair value, and the notes will not be listed on any exchange. Up-front selling concession is 2.25% of principal.
Key risks highlighted include: potential loss of principal, coupon discontinuation if the threshold is breached, early-call reinvestment risk, limited liquidity, valuation discounts in secondary trading, uncertain tax treatment, and UBS credit exposure (including possible FINMA-mandated bail-in or restructuring).